References
- Miller DB: The price of freedom. J Craniomandib Pract 2011; 29(1):1–5.
- Greene CS: Managing the care of patients with temporomandibular disorders: a new guideline for care. J Am Dent Assoc 2010; 141(9):1086–1088.
- Greene CS: Diagnosis and treatment of temporomandibular disorders: emergence of new care guidelines statement. Oral Surg, Oral Med, Oral Pathol, Oral Radiol, Endodont 2010; 110(2):137–139.
- Manfredini, et al.: Kinesiographic recordings of jaw movements are not accurate to detect magnetic resonance-diagnosed temporomandibular joint (TMJ) effusion and disk displacement:findings from a validation study. Oral Surg, Oral Med, Oral Pathol, Oral Radiol, Endodont 2010; 114(4): 457–463.
- Mohl ND: Status report on devices for the diagnosis and treatment of temporomandibular disorders. American Dental Association Council on Scientific Affairs, Draft Letter Aug 18, 1988
- Mohl ND, Lund JP, Widmer CG, McCall WD: Devices for the diagnosis and treatment of temporomandibular disorders. Part III: Electromyography and sonography. J Prosth Dent 1990; 63(3):332–335.
- Greene, CS: An evaluation of unconventional methods of diagnosing and treating temporomandibular disorders. Oral and Maxillofacial Surgery Clinics of North America 1995; 7(1):167–173.
- Lund JP, Lavigne G, Feine JS, et al.: The use of electronic devices in the diagnosis and treatment of temporomandibular disorders. J Craniomand Disorders 1989; 3(3):125–137.
- FDA Office of Internal Affairs Memorandum: Greene interviewed by Special Agents Drezek and Kochanski. Case #95–0IA-970-074. Case title: FDA Retaliation, Aug 26, 1996.
- FDA Office of Internal Affairs letter attachment to file. Case #95-OIA-970-074. Letter of correspondence from CS Greene to Drs. Tylenda and Singleton, Dental Products Food and Drug Administration, Aug 10, 1994.
- Dickinson’s FDA Review: Biased advisors: FDA slaps staffers as probes continue. 1997; Sept:6.
- Hearings before the Subcommittee on Oversight and Investigation of the Committee on Commerce, House of Representatives, 104th Congress, July 25, Nov 15, Dec 5, 1995. Serial No 104–151.
- Dickinson’s FDA Review: Perverted FDA officials under criminal probe. 1995; 2(8):21.
- M-D-D-I Reports, The Gray Sheet Dental Products: Advisory Panel Chair resigns following release of IG probe. 1997; 20(Oct):6.
- Canadian Agency for Drugs and Technologies in Health Rapid Response Report: Neuromuscular occlusion for diagnosis and treatment of temporomandibular disorders: a review of the clinical evidence. January 11, 2013. Reprinted online Journal of the Canadian Dental Association JCDAClinical Q&A March 11, 2013.
- Manfredini D, et al.: An assessment of the usefulness of jaw kinesiography in monitoring temporomandibular disorders: Correlation of treatmentrelated kinesiographic and pain changes in patients receiving temporomandibular joint injections. J Am Dent Assoc 2013; 144(4):397–405.